Patients with primary immunodeficiency autoimmune polyendocrine syndrome type I (APS-I) suffer from chronic mucocutaneous candidiasis (CMC) and are shown to have increased serum titers of AAbs to IL−17A/F and IL−22 (10). Here, IL22 is linked to chronic mucocutaneous candidiasis.